{"id":"W3204588330","doi":"10.1016/j.annonc.2021.08.1489","title":"1380P Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre","funders":"Astellas Pharma; Natera; Pharmacyclics; MacroGenics; BeiGene; Daiichi Sankyo Europe; Eli Lilly and Company; Bristol-Myers Squibb; Incyte; Amgen","keywords":"Medicine; Internal medicine; Hypokalemia; Oxaliplatin; Gastroenterology; Vomiting; Nausea; Capecitabine; Adverse effect; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009283256,0.0002451958,0.001141841,0.0002979299,0.00007490803,0.000009519046,0.0003275086,0.0002279197,0.001136582],"category_scores_gemma":[0.0004379507,0.0002431248,0.0001430139,0.0006430386,0.0002262585,0.000107698,0.0002855383,0.0005541551,0.000009457138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001564443,"about_ca_system_score_gemma":0.0009591588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004524407,"about_ca_topic_score_gemma":0.0004989855,"domain_scores_codex":[0.9969248,0.0003146063,0.0009286894,0.000569953,0.0006258981,0.0006360546],"domain_scores_gemma":[0.9978172,0.0002767416,0.0002959466,0.0008115501,0.0005764193,0.0002222025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01204178,0.06983981,0.3103701,0.001482713,0.001008356,0.009467173,0.01872245,0.0001773217,0.2147349,0.00005572688,0.02757416,0.3345254],"study_design_scores_gemma":[0.07482397,0.08647568,0.2026775,0.000961712,0.0001915953,0.0006084811,0.007254859,0.0008041391,0.5926231,0.0002269961,0.03281339,0.0005386485],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988616,0.002327961,0.00005095874,0.006570379,0.0001399171,0.00071986,0.00004160955,0.00002388144,0.001509395],"genre_scores_gemma":[0.9965077,0.0005455284,0.001023685,0.001076409,0.0002598586,0.00006107274,0.00004787383,0.00005133812,0.0004265175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3778881,"threshold_uncertainty_score":0.9997765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.161775781532972,"score_gpt":0.4767629339354125,"score_spread":0.3149871524024406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}